BUENA, N.J., Feb. 27, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at The 8^th Annual SVB Leerink Global Healthcare Conference March 1, 2019. The Conference is taking place February 27^th-March 1^st, 2019 at the Lotte New York Palace, New York.

Damian Finio, Chief Financial Officer of Teligent, Inc., will present on Friday March 1^st at 11:00 a.m. ET.

The presentation will be webcast and accessible online via the investors section of the Company's website at www.teligent.com.  A replay will be available for 30 days.

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.